Expression and Significance of microRNA-21 and EGFR in Non-small Cell Lung Cancer
-
摘要:
目的 研究microRNA-21及其调控基因EGFR在非小细胞肺癌-肺腺癌和鳞癌中的表达及意义。 方法 以 2020年 10月至 2020 年 12 月于昆明医科大学第一附属医院就诊的30例经病理确诊的非小细胞肺癌患者的肺组织标本作为研究对象，包括肺腺癌24例和肺鳞癌6例，同时以癌旁肺组织作为对照。实时定量PCR检测microRNA-21的表达，免疫组织化学方法检测microRNA-21调控基因EGFR的蛋白表达和定位。 结果 癌旁肺组织中microRNA-21和EGFR表达水平较低，与癌旁组织比较，肺腺癌和肺鳞癌组织中microRNA-21和EGFR表达均明显上调，差异有统计学意义（P < 0.01）；与肺腺癌组织比较，肺鳞癌组织中的microRNA-21和EGFR表达明显升高，差异有统计学意义（P < 0.05）。 结论 microRNA-21及其调控基因EGFR在非小细胞肺癌-肺腺癌和鳞癌中呈高表达，且表达趋势一致，可预测非小细胞肺癌的进展与预后。 -
关键词:
- 非小细胞肺癌 /
- microRNA-21 /
- 肺腺癌 /
- 肺鳞癌 /
- EGFR
Abstract:Objective To explore the expression and significance of microRNA-21 and its regulatory gene EGFR in non-small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma. Methods Lung tissue samples of 30 patients with pathologically confirmed non-small cell lung cancer from October 2020 to December 2020 in The 1st Affiliated Hospital of Kunming Medical University were taken as the research objects, including 24 cases of lung adenocarcinoma and 6 cases of lung squamous cell carcinoma, and the lung tissue adjacent to cancer was taken as the control. The expression of microRNA-21 was detected by real-time quantitative PCR, and the protein expression and localization of EGFR were detected by immunohistochemistry. Results The expression levels of microRNA-21 and EGFR in lung tissue adjacent to cancer were lower. Compared with lung tissue adjacent to cancer, the expression levels of microRNA-21 and EGFR in lung adenocarcinoma and lung squamous cell carcinoma were significantly increased （P < 0.01）; compared with lung adenocarcinoma, the expression levels of microRNA-21 and EGFR in lung squamous cell carcinoma were significantly increased （P < 0.05）. Conclusion MicroRNA-21 and its regulatory gene EGFR are highly expressed in NSCLC lung adenocarcinoma and squamous cell carcinoma, and the expression trend is consistent, which can be used to predict the progress and prognosis of NSCLC. -
Key words:
- Non small cell lung cancer /
- MicroRNA-21 /
- Lung adenocarcinoma /
- Lung squamous cell carcinoma /
- EGFR
-
图 1 典型非小细胞癌-肺腺癌与鳞癌的病理特征（HE染色，200 ×）
A：癌旁肺组织；B：肺腺癌；C肺鳞癌。
Figure 1. Pathological features of lung adenocarcinoma and squamous cell carcinoma （HE staining，200 ×）
图 2 典型非小细胞癌-肺腺癌与鳞癌的特征性标志物表达（免疫组化 200 ×）
A：癌旁肺组织TTF-1；B：肺腺癌TTF-1；C肺鳞癌P40。
Figure 2. Expression of characteristic markers in typical non-small cell carcinoma lung adenocarcinoma and squamous cell carcinoma （Immunohistochemical staining 200 ×）
图 3 非小细胞癌-肺腺癌与鳞癌中microRNA-21表达（
$\bar x \pm s $ ）与癌旁肺组织比较，**P < 0.01；与肺腺癌比较，#P < 0.05。
Figure 3. Expression of microRNA-21 in non-small cell carcinoma-lung adenocarcinoma and squamous cell carcinoma（
$\bar x \pm s $ ）
图 4 非小细胞癌-肺腺癌与鳞癌中EGFR蛋白表达（免疫组化，200 ×）
A：癌旁肺组织EGFR；B：肺腺癌EGFR；C肺鳞癌EGFR。
Figure 4. Expression of EGFR protein in non-small cell carcinoma-lung adenocarcinoma and squamous cell carcinoma （immunohistochemistry，200 ×）
图 5 非小细胞癌-肺腺癌与鳞癌中EGFR蛋白表达评分（
$\bar x \pm s $ ）与癌旁肺组织比较，**P < 0.01；与肺腺癌比较，#P < 0.05。
Figure 5. EGFR protein expression score in non-small cell carcinoma lung adenocarcinoma and squamous cell carcinoma（
$\bar x \pm s $ ）表 1 microRNA-21和内参U6的引物序列
Table 1. Primer sequences of microRNA-21 and internal reference U6
基因 引物序列 miR-21 F：5′-ACGTTGTGTAGCTTATCAGACTG-3′ R：5′-AATGGTTGTTCTCCACACTCTC-3′ 内参U6 F：5′-ATTGGAACGATACAGAGAAGATT-3′ R：5′-GGAACGCTTCACGAATTTG-3′ 
下载: 导出CSV
-
[1] Wen T,Song L,Hua S. Perspectives and controversies regarding the use of natural products for the treatment of lung cancer[J]. Cancer Med,2021,10(7):2396-2422. doi: 10.1002/cam4.3660 [2] Liu Y,Chen P,Wang H,et al. The landscape of immune checkpoints expression in non-small cell lung cancer:A narrative review[J]. Transl Lung Cancer Res,2021,10(2):1029-1038. doi: 10.21037/tlcr-20-1019 [3] Sekar D. miRNA 21:A novel biomarker in the treatment of bladder cancer[J]. Biomark Med,2020,14(12):1065-1067. doi: 10.2217/bmm-2020-0319 [4] Hao B,Zhang J. miRNA-21 inhibition suppresses the human epithelial ovarian cancer by targeting PTEN signal pathway[J]. Saudi J Biol Sci,2019,26(8):2026-2029. doi: 10.1016/j.sjbs.2019.08.008 [5] Hetta H F,Zahran A M,Shafik E A,et al. Circulating miRNA-21 and miRNA-23a expression signature as potential biomarkers for early detection of non-small-cell lung cancer[J]. Microrna,2019,8(3):206-215. doi: 10.2174/1573399815666190115151500 [6] Markou A,Zavridou M,Lianidou ES. miRNA-21 as a novel therapeutic target in lung cancer[J]. Lung Cancer (Auckl),2016,7(1):19-27. [7] 支修益,石远凯,于金明. 中国原发性肺癌诊疗规范(2015年版)[J]. 中华肿瘤杂志,2015,37(1):67-78. doi: 10.3760/cma.j.issn.0253-3766.2015.01.014 [8] 陈希. miRNA与疾病关联预测算法研究[D], 哈尔滨: 哈尔滨工业大学硕士论文, 2018. [9] 吴艳玲,李升锦. miRNA与呼吸系统疾病关系的研究进展[J]. 世界最新医学信息文摘,2020,20(32):59-60,64. [10] 殷敏,杜敏,刘彤. 血清miRNA与肺癌的诊断及预后进展[J]. 西南军医,2021,23(1):38-41. doi: 10.3969/j.issn.1672-7193.2021.01.010 [11] 孙站兵,邓伟华,刘艳萍,等. 基于数据库中肺纤维化miRNA及肺癌mRNA芯片资料分析筛查肺癌的潜在治疗靶点[J]. 生命的化学,2021,41(1):133-142. [12] Li S,Zeng X,Ma R,et al. MicroRNA-21 promotes the proliferation,migration and invasion of non-small cell lung cancer A549 cells by regulating autophagy activity via AMPK/ULK1 signaling pathway[J]. Exp Ther Med,2018,16(3):2038-2045. [13] Zheng W,Zhao J,Tao Y,et al. MicroRNA-21:A promising biomarker for the prognosis and diagnosis of non-small cell lung cancer[J]. Oncol Lett,2018,16(3):2777-2782. [14] 洪雅敏,涂蓉,尤晓光. 表皮生长因子受体与肿瘤分子成像研究进展[J]. 国际医学放射学杂志,2020,43(5):586-590. [15] Wang J X,Wu H L,Zhu M,et al. Role of anti-epidermal growth factor receptor therapy compared with anti-vascular endothelial growth factor therapy for metastatic colorectal cancer:An update meta-analysis of randomized clinical trials[J]. Pathol Oncol Res,2020,26(1):159-166. doi: 10.1007/s12253-017-0365-5 -
点击查看大图
计量
- 文章访问数: 4874
- HTML全文浏览量: 2897
- PDF下载量: 34
- 被引次数: 0
